Creative Planning’s Twist Bioscience TWST Stock Holding History

Creative Planning’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.82M	Buy	46,807 +17,559	+60%	+$1.14M	﹤0.01%	1437
2026 Q1	$1.39M	Buy	29,248 +19,037	+186%	+$854K	﹤0.01%	2201
2025 Q4	$324K	Buy	+10,211	New	+$319K	﹤0.01%	3188
2025 Q2	–	Sell	-7,000	Closed	-$275K	–	3794
2025 Q1	$275K	Buy	7,000 +1,977	+39%	+$89K	﹤0.01%	2835
2024 Q4	$233K	Buy	5,023 +377	+8%	+$17K	﹤0.01%	2861
2024 Q3	$210K	Sell	4,646 -405	-8%	-$19.3K	﹤0.01%	2797
2024 Q2	$249K	Buy	+5,051	New	+$206K	﹤0.01%	2508
2023 Q2	–	Sell	-30	Closed	-$453	–	2832
2023 Q1	$453	Buy	+30	New	+$663	﹤0.01%	2590
2021 Q3	–	Sell	-3,950	Closed	-$526K	–	2228
2021 Q2	$526K	Buy	+3,950	New	+$459K	﹤0.01%	1250

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Creative Planning's TWST Position: Q2 2026 in Review

Creative Planning increased its Twist Bioscience (TWST) stake by 60% in Q2 2026, buying an estimated $1.14M and bringing the position to 46,807 shares worth $4.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

Creative Planning first reported a position in TWST in Q2 2021 and has held it in 9 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Creative Planning held 46,807 shares of Twist Bioscience worth $4.82M as of Q2 2026.
Creative Planning bought 17,559 Twist Bioscience shares in Q2 2026, an estimated $1.14M.
Twist Bioscience made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1437 holding.
Creative Planning first reported a position in Twist Bioscience in Q2 2021 and has held it in 9 quarters since.
338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.